Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture

Cardiovascular Research

Volumn 37, Issue 1, 1998, Pages 254-262

  Adner, Mikael ^a   Uddman, Erik ^a   Cardell, Lars Olaf ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelin; ET(A) receptor; ET(B) receptor; Organ culture; Plasticity; Rat; Sarafotoxin

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N (3,5 DIMETHYLBENZOYL) N METHYL (4 PHENYLPHENYL)ALANYLTRYPTOPHAN; SARAFOTOXIN S6C; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FEMORAL ARTERY; FEMORAL VEIN; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY;

ANIMALS; AORTA; ENDOTHELIN-1; FEMORAL ARTERY; FEMORAL VEIN; LINEAR MODELS; MALE; MESENTERIC ARTERIES; MESENTERIC VEINS; MUSCLE, SMOOTH, VASCULAR; ORGAN CULTURE TECHNIQUES; RATS; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; STATISTICS, NONPARAMETRIC; TAIL; VASOCONSTRICTOR AGENTS; VIPER VENOMS;

EID: 0031912193     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00206-X     Document Type: Article

References (40)

1. Yanagisawa M., Kurihara H., Kimura S.et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
2. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
3. Sakurai T., Yanagisawa M., Takuwa Y.et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
4. de Nucci G., Thomas R., D'Orleans J.P.et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 85:1988;9797-9800.
5. B-receptor stimulation on arterial, venous and capillary functions in cat skeletal muscle. Br J Pharmacol. 112:1994;887-894.
6. B-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat. Br J Pharmacol. 107:1992;912-918.
7. 1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala[11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol. 112:1994;477-486.
8. Haynes W.G., Strachan F.E., Webb D.J. Endothelin ET(A) and ET(B) and receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 92:1995;357-363.
9. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun. 186:1992;867-873.
10. Moreland S., McMullen D., Abboa-Offei B., Seymour A. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Br J Pharmacol. 112:1994;704-708.
11. Mulvany M.J. Vascular structure and smooth muscle contractility in experimental hypertension. J Cardiovasc Pharmacol. 10(Suppl. 6):1987;S79-S85.
12. Shetty S.S., Okada T., Webb R.L., DelGrande D., Lappe R.W. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun. 191:1993;459-464.
13. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 89:1994;1203-1208.
14. B receptors in venous and arterial smooth muscle. Eur J Pharmacol. 287:1995;279-285.
15. B receptors mediating constriction and relaxation? J Cardiovasc Pharmacol. 26:1995;S262-S264.
16. B receptors in rat small mesenteric arteries. Br J Pharmacol. 120:1997;1376-1382.
17. A receptor in human arteries in vitro. J Cardiovasc Pharmacol. 26(Suppl. 3):1995;S314-S316.
18. Adner M., Cantera L., Ehlert F., Nilsson L., Edvinsson L. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol. 119:1996;1159-1166.
19. Barber D.A., Michener S.R., Ziesmer S.C., Miller V.M. Chronic increases in blood flow upregulate endothelin-B receptors in arterial smooth muscle. Am J Physiol. 39:1996;H65-H71.
20. Cannan C.R., Burnett J.C., Lerman A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. Circulation. 93:1996;646-651.
21. Dagassan P.H., Breu V., Clozel M.et al. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol. 27:1996;147-153.
22. Wenzel R.R., Duthiers N., Noll G., Bucher J., Kaufmann U., Luscher T.F. Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. Circulation. 94:1996;316-322.
23. Abrol R.P., Hughes W.M., Krueger G.A., Cook D.A. Detection of endothelium in cerebral blood vessels. J Pharmacol Methods. 12:1984;213-219.
24. 2 and receptor differentiation: A statistical analysis of competitive antagonism. Life Sci. 25:1979;637-654.
25. B receptors mediate vascular smooth muscle contraction. Br J Pharmacol. 107:1992;858-860.
26. D'Orleans J.P., Claing A., Warner T.D., Yano M., Telemaque S. Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br J Pharmacol. 110:1993;687-692.
27. Cocks T.M., Broughton A., Dib M., Sudhir K., Angus J.A. Endothelin is blood vessel selective: studies on a variety of human and dog vessels in vitro and on regional blood flow in the conscious rabbit. Clin Exp Pharmacol Physiol. 16:1989;243-246.
28. Chen L.H., Mcneill J.R., Wilson T.W., Gopalakrishnan V. Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels. Br J Pharmacol. 114:1995;1599-1604.
29. Black J.W., Leff P. Operational models of pharmacological agonism. Proc R Soc Lond. 220:1983;141-162.
30. B receptors after organ culture. Eur J Pharmacol 1997;329:69-77.
31. Deng L.-Y., Li J.-S., Schiffrin E.L. Endothelin receptor subtypes in resistance arteries from humans and rats. Cardiovasc Res. 29:1995;532-535.
32. Saeki T., Ihara M., Fukuroda T., Yamagiwa M., Yano M. [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity. Biochem Biophys Res Commun. 179:1991;286-292.
33. Williams D.L., Jones K.L., Pettibone D.J., Lis E.V., Clineschmidt B.V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun. 175:1991;556-561.
34. A receptor antagonist. J Pharmacol Exp Ther. 264:1993;1040-1046.
35. Clozel M., Breu V., Gray G.A.et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 270:1994;228-235.
36. Mauger J.P., Worcel M., Tassin J., Courtois Y. Contractility of smooth muscle cells of rabbit aorta in tissue culture. Nature. 255:1975;337-338.
37. De Mey J.G.R., Uitendaal M.P., Boonen H.C.M., Vrijdag M.J.J.F., Daemen M.J.A.P., Struyker-Boudier H.A.J. Acute and long-term effects of tissue culture on contractile reactivity in renal arteries of the rat. Circ Res. 65:1989;1125-1135.
38. Daemen J.A.P., De Mey J.G.R. Regional heterogeneity of arterial structural changes. Hypertension. 25:1995;464-473.
39. Eguchi S., Hirata Y., Imai T., Kanno K., Marumo F. Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology. 134:1994;222-228.
40. Adner M, Geary GG, Edvinsson L. Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. Acta Physiol Scand 1997;in press.